Thomas David Hull III Sells 3,000 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 3,000 shares of Kewaunee Scientific stock in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of $45.63, for a total value of $136,890.00. Following the completion of the sale, the chief executive officer now owns 37,916 shares of the company’s stock, valued at approximately $1,730,107.08. The trade was a 7.33 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Thomas David Hull III also recently made the following trade(s):

• On Friday, March 21st, Thomas David Hull III sold 213 shares of Kewaunee Scientific stock. The stock was sold at an average price of $48.53, for a total transaction of $10,336.89.
• On Friday, January 10th, Thomas David Hull III sold 1,368 shares of Kewaunee Scientific stock. The shares were sold at an average price of $60.08, for a total transaction of $82,189.44.
• On Thursday, December 26th, Thomas David Hull III sold 2,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $63.01, for a total transaction of $126,020.00.

Kewaunee Scientific Stock Performance

KEQU opened at $40.60 on Wednesday. The company has a market cap of $115.91 million, a price-to-earnings ratio of 6.43 and a beta of 0.71. The company’s fifty day moving average price is $56.95 and its two-hundred day moving average price is $47.55. Kewaunee Scientific Co. has a 1-year low of $30.82 and a 1-year high of $71.33. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. The business had revenue of $67.17 million for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Kewaunee Scientific from a “buy” rating to a “hold” rating in a research note on Friday, March 14th.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of KEQU. Bank of America Corp DE raised its position in Kewaunee Scientific by 2,605.9% in the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock valued at $28,000 after buying an additional 443 shares during the last quarter. Jane Street Group LLC purchased a new stake in shares of Kewaunee Scientific in the fourth quarter valued at about $300,000. Marshall Wace LLP bought a new position in shares of Kewaunee Scientific during the fourth quarter valued at about $736,000. Invesco Ltd. purchased a new position in Kewaunee Scientific during the fourth quarter worth about $6,545,000. Finally, Wedbush Securities Inc. bought a new stake in Kewaunee Scientific in the 4th quarter worth about $262,000. Institutional investors own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.